• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨细胞病毒感染

Cytomegalovirus infection.

作者信息

Aulitzky W E, Hengster P, Tilg H, Schulz T, Dierich M, Huber C

机构信息

Department for Internal Medicine, University Hospital, Innsbruck.

出版信息

Wien Klin Wochenschr. 1988 Jan 22;100(2):33-43.

PMID:2831672
Abstract

Interest has focused on cytomegalovirus (CMV) infections during recent years for two reasons: First, the number of immunocompromised patients with CMV infections has risen continuously and, secondly, recent advances in basic research have clarified some of the mechanisms of persistent and recurrent CMV infection. Three different clinical pictures can arise with CMV infection. In healthy individuals most of the CMV infections are not clinically apparent. In immunocompromised patients CMV causes a wide spectrum of diseases and is one of the predominant causes of death in AIDS patients and bone marrow transplant recipients. The most important problem for public health associated with CMV are connatal and perinatal CMV infections. Progress has been made with treatment of CMV infection in immunocompromised patients with inhibitors of viral replication.

摘要

近年来,人们对巨细胞病毒(CMV)感染的关注集中在两个原因上:第一,感染CMV的免疫功能低下患者数量持续上升;第二,基础研究的最新进展阐明了CMV持续感染和复发感染的一些机制。CMV感染可出现三种不同的临床症状。在健康个体中,大多数CMV感染没有临床症状。在免疫功能低下的患者中,CMV会引发多种疾病,是艾滋病患者和骨髓移植受者的主要死亡原因之一。与CMV相关的公共卫生最重要问题是先天性和围生期CMV感染。在使用病毒复制抑制剂治疗免疫功能低下患者的CMV感染方面已取得进展。

相似文献

1
Cytomegalovirus infection.巨细胞病毒感染
Wien Klin Wochenschr. 1988 Jan 22;100(2):33-43.
2
Characteristics of cutaneous cytomegalovirus infection in non-acquired immune deficiency syndrome, immunocompromised patients.非获得性免疫缺陷综合征免疫功能低下患者皮肤巨细胞病毒感染的特征
Br J Dermatol. 2006 Nov;155(5):977-82. doi: 10.1111/j.1365-2133.2006.07456.x.
3
Pathogenesis of cytomegalovirus pneumonia in immunocompromised hosts.免疫功能低下宿主巨细胞病毒肺炎的发病机制。
Semin Respir Infect. 1995 Dec;10(4):199-208.
4
[Cytomegalovirus disease in immunocompromised patients].[免疫功能低下患者的巨细胞病毒病]
Med Arh. 2000;54(1):9-11.
5
Cytomegalovirus infection in immunocompetent and immunocompromised individuals--a review.免疫功能正常和免疫功能低下个体的巨细胞病毒感染——综述
Curr Drug Targets Immune Endocr Metabol Disord. 2001 Aug;1(2):179-87.
6
Cytomegalovirus pneumonia: presentation, diagnosis, and treatment.巨细胞病毒肺炎:临床表现、诊断与治疗
Semin Respir Infect. 1995 Dec;10(4):209-15.
7
Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.在进展为艾滋病合并巨细胞病毒终末器官疾病的HIV-1感染个体中,巨细胞病毒(CMV)特异性T细胞的动力学变化。
J Infect Dis. 2005 Mar 15;191(6):873-80. doi: 10.1086/427828. Epub 2005 Jan 31.
8
The effect of cytomegalovirus infection on T lymphocytes after allogeneic bone marrow transplantation.巨细胞病毒感染对异基因骨髓移植后T淋巴细胞的影响。
Clin Exp Immunol. 1985 Nov;62(2):278-87.
9
Cytomegalovirus infection in the acquired immunodeficiency syndrome. Clinical and autopsy findings.获得性免疫缺陷综合征中的巨细胞病毒感染。临床及尸检结果。
Arch Pathol Lab Med. 1988 May;112(5):540-4.
10
Major expansion of gammadelta T lymphocytes following cytomegalovirus infection in kidney allograft recipients.肾移植受者巨细胞病毒感染后γδ T淋巴细胞大量扩增。
J Infect Dis. 1999 Jan;179(1):1-8. doi: 10.1086/314568.

引用本文的文献

1
Infections and Chronic Inflammatory Bowel Disease.感染与慢性炎症性肠病
Viszeralmedizin. 2014 Oct;30(5):326-32. doi: 10.1159/000366463.
2
[Is it possible to reduce CMV-infections after heart transplantation with a three-month antiviral prophylaxis? 7 years experience with ganciclovir].[心脏移植后进行为期三个月的抗病毒预防能否降低巨细胞病毒感染?使用更昔洛韦的7年经验]
Wien Klin Wochenschr. 2004 Aug 31;116(15-16):542-51. doi: 10.1007/BF03217708.
3
Increased expression of IgG Fc receptor type I on neutrophils and monocytes from HIV-infected subjects.
来自HIV感染受试者的中性粒细胞和单核细胞上I型IgG Fc受体表达增加。
Clin Exp Immunol. 1992 Nov;90(2):175-80. doi: 10.1111/j.1365-2249.1992.tb07924.x.